Choriogonadotropin alfa biosimilar - Dong-A ST

Drug Profile

Choriogonadotropin alfa biosimilar - Dong-A ST

Alternative Names: DA 3803; r-hCG

Latest Information Update: 11 Sep 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dong-A Pharmaceutical
  • Developer Dong-A ST
  • Class Gonadotropins; Infertility therapies; Peptide hormones; Pituitary gonadotropins; Placental hormones; Recombinant proteins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Female infertility

Highest Development Phases

  • No development reported Female infertility

Most Recent Events

  • 11 Sep 2018 No development reported - Preregistration for Female infertility in South Korea (SC)
  • 26 May 2015 Choriogonadotropin alfa biosimilar - Dong-A ST is available for licensing in World as of 26 May 2015.
  • 26 May 2015 Dong A announces intention to submit NDA to KFDA (Dong-A ST 1Q report, May 2015)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top